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ABSTRACT
Poorly designed wound trials that generate knowl-
edge that does not inform clinical practice consti-
tute an example of research waste that undermines 
evidence-based healthcare. Well-designed trials 
that generate clinically relevant and robust knowl-
edge are integral to improving health nationwide 
and achieving universal health coverage.
This paper critically analyses the existing challenges 
associated with improving trials as well as how these 
challenges can be overcome through a research 
community of practice, such as the Wounds Re-
search Network (WReN).
Although a wide range of people have a stake in 
improving wound trials, they often belong to dif-
ferent social or professional groups that can make 
collaborative work challenging. In the UK, WReN 
demonstrates how a unifying national research 
community of practice can help people work to-
gether to design and conduct studies that generate 
knowledge that may help improve patient care.
Key Message
• Communities of practice such as the WReN are 
a useful resource for improving wound trials to gen-
erate knowledge that informs clinical practice and 
contributes to the establishment of universal health 
coverage.
Wounds Research Network 
(WReN) - a community of 
practice for improving wound 
care-related trials
INTRODUCTION
Poorly designed wound trials that do not generate 
knowledge that clinicians can utilise to inform 
patient care constitute an example of research 
waste,1-4 which undermines efforts to deliver 
person-centred, evidence-based healthcare to all. 
A lively debate has long surrounded the wound 
healing community regarding a trial’s ability to 
generate evidence that clinicians may use to in-
form patient care.5-9 The shortcomings and flaws 
associated with wound-related trials and their in-
ability to generate knowledge that may inform 
patient care are well known.5,8,10 Designing trials 
that generate clinically relevant knowledge at a 
national level may be challenging because many 
people with wounds have other co-morbidities 
and because healthcare is delivered via complex 
adaptive systems.7,10,11 
Quality improvement efforts in complex adaptive 
systems such as healthcare can fail with disastrous 
consequences and devastating outcomes.12 Poorly 
designed trials contribute to negative perceptions 
amongst clinicians, policymakers, researchers, 
healthcare commissioners, and funders regarding 
research’s ability to improve the quality of wound 
care and patient outcomes.5,6,10 However, the 
consequences of poorly designed trials extend far 
beyond wound healing in that they undermine 
efforts to promote evidence-based healthcare.2,4 
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Some have argued6-8 that it would be most beneficial to 
adopt a different approach to evidence-based wound care 
in which there exists less reliance on evidence from trials 
and clinical practice is informed by evidence from studies 
that employ other research methods. 
Adopting a broader approach to evidence-based wound 
care and using other research methods may generate use-
ful insights that inform patient care. However, the global 
focus is on universal health coverage in which everyone has 
access to care that is delivered in a just, equitable, and safe 
manner.13 Achieving universal health coverage requires a 
population approach to healthcare in which the national 
focus is on improving the health and well-being of every 
citizen.13 Therefore, it is important  for researchers and 
clinicians to consider how wound care trials can be im-
proved to inform patient care at a national level.
This paper examines key elements of the wider debate on 
improving healthcare-related trials before exploring how 
wound care trials can be improved through a research 
community of practice. The nature and purpose of a com-
munity of practice is summarised with an exploration into 
how it might contribute to improved wound trials. The 
Wounds Research Network (WReN) is then applied as 
a case study of a community of practice that was created 
by the Tissue Viability Society to improve wound trials in 
the UK. This paper concludes with a discussion of how 
research communities of practice such as the WReN can 
improve a trials’ ability to generate knowledge that helps 
achieve universal health coverage in wound care. 
Improving clinical trials 
Poor trials are not unique to wound care, as many exam-
ples exist of research waste caused by poor trials in other 
aspects of healthcare.2-4 Trials can be improved in a vari-
ety of ways, such as by creating more appropriate report-
ing standards,2,3,14 improving the methods applied,1,3 or 
improving regulation.15 However, the definition of what 
constitutes a good trial changes over time as new and in-
novative trial designs emerge.14 Therefore, the design and 
conduct of trials at any given time are socially mediated 
and defined. In other words, what is considered a good 
trial at any point in time is strongly influenced by the 
views of the wider research community. In the rapidly 
evolving world of research, the prevailing consensus within 
the research community concerning the most appropriate 
methods for the design and reporting of trials solely exists 
until the next methodological innovations emerge.3,14 The 
rapid pace of methodological innovation implies that the 
consensus as to the best practice regarding the design and 
conduct of trials in the wider research community is con-
stantly evolving.14 The nature and pace of change in trial 
design can make it challenging for clinicians to understand 
how they may most effectively apply the evidence they 
generate to inform patient care.14
Various groups of people are interested in improving the 
quality of wound trials and research. People who have a 
stake in improving wound trials originate from diverse 
professions or backgrounds, although they can be broadly 
be categorised as patients, informal caregivers, informal 
patient networks, policymakers, academics/researchers, 
clinicians, and industry enterprise employees. The rela-
tionships between these different groups have at times 
been fraught with tension due to differing perspectives and 
commercial interests, specifically with regard to the use of 
evidence to inform practice, which affects the quality of 
wound care that patients receive.8,10,16 From an intellectual 
perspective, each group of people interested in improving 
the quality of wound trials can be considered a commu-
nity of practice.17-20 This conceptualisation is appropriate 
because people who belong to the research community 
decide what may be considered a good trial.14 Therefore, 
it is important to establish what a community of practice 
is and how it is relevant to improving wound trials.
Communities of practice 
A community of practice is a group of people who form 
relationships with one another based on a shared interest 
in improving some aspect of their practice, who work to-
gether, and who utilise their collective expertise to achieve 
a shared goal.18-20 Many different groups of people are 
interested in improving wound care, including surgeons, 
doctors, nurses, physiotherapists, and patients. Conse-
quently, each of these groups can be considered a com-
munity of practice in its own right. People who belong to 
a formal or informal community of practice learn from 
one another as they use their shared expertise to achieve 
their overarching goals.17,18,20 Some examples of knowl-
edge sharing between professional and patient groups may 
be found in wound care centres of excellence and wound 
care clubs.21, 22
Over time, the people within a community of practice 
develop a shared identity and a set of values that can estab-
lish boundaries in collaborative work.19,20,23 Boundaries 
between people who belong to different professions and 
groups can be an impediment to the adoption of a col-
laborative evidence-based approach to delivering patient-
centred wound care.6 8,10,16,24 The concept of a community 
of practice has been applied to refer to several aspects,25 
and it is important that its relation to improving wound 
trials and research is clarified. In this paper, a community 
of practice refers to people who hold differing values as a 
result of their professions or backgrounds but neverthe-
less share the common interest of improving wound trials 
and research.
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The Wounds Research Network
A critical mass of researchers, academics clinicians, and 
patients in the UK have undertaken a wide range of inno-
vative trials in pressure ulcers,26,27 leg ulcers,28-30 burns,31 
and other types of wounds.32-37 The Tissue Viability Soci-
ety created the WReN (https://woundsrn.org/) in 2015 to 
provide an interprofessional cross-speciality forum where 
people may share their knowledge, expertise, and insights 
regarding wound trials and research. The WReN offers 
opportunities to people from diverse backgrounds to fur-
ther develop their knowledge and expertise in conducting 
high-quality wound trials and research regardless of their 
levels of expertise. Therefore, WReN is a community of 
practice that has helped overcome some research-related 
barriers to collaboration that exist between various profes-
sions and specialities in the UK. 
Trials in any aspect of healthcare can be improved through 
more efficient reporting, methods, or regulation.1-3,14,15 
However, the notion of improving the design and conduct 
of trials through a unifying community of practice such 
as WReN has not been previously reported. As such, ex-
ploring the benefits of a community of practice approach 
to improving wound trials and research (e.g., WReN) in 
other nations is worthwhile. A pragmatic first step towards 
achieving universal health coverage in wound care may, 
perhaps, involve the creation of national research com-
munities of practice that focus on improving the quality 
of wound trials and research.
CONCLUSION
This paper has considered the challenges that exist with 
regard to improving trials to generate knowledge that cli-
nicians may utilise to achieve universal health coverage 
in wound care. This paper has explored the case of the 
WReN, which functions as a community of practice that 
brings together people in the UK to improve wound trials 
and research. The WReN is an example of how a national 
research community of practice may facilitate interprofes-
sional and cross-speciality collaboration as well as improve-
ment in wound trials. National research communities of 
practice can help overcome the boundaries between vari-
ous professions and groups of people that hinder teamwork 
in wound trials and research. The author hopes this paper 
inspires an international audience of people interested in 
improving wound trials to work collaboratively with others 
in a national research community of practice to achieve 
universal health coverage.
IMPLICATIONS FOR FUTURE PRACTICE
 n  Wound trials and research must be improved to generate 
 knowledge that informs patient care at a national level.
 n  A national wounds research community of practice 
 can provide a forum for shared learning and collabora-
 tion among people from diverse backgrounds.
FURTHER RESEARCH
 n  The effectiveness of research communities of practice 
 in improving trials’ design and conduct must be 
 established in future research.
 n  It is important that future research consider other 
 approaches to improving trials that acknowledge the 
 social and collaborative nature of research in a context 
 with rapidly evolving methodological innovations.
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